chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received her Covid19 Vaccine and started to feel dizzy. Paramedic assisted the Pt to the bed, where the Pt laid down, Paramedic obtained vitals and assisted the Pt to control her breathing. Paramedic contacted Dr and was informed to monitor the Patient. The Pt relayed to Paramedic that she wanted to walk around. The Patient relayed to Paramedic that she felt much better. Paramedic obtained three sets of vitals which were all in normal range. The Patient relayed to Paramedic that she was no longer feeling symptoms. Paramedic walked the Patient to the Front door. BP 160/90 RR18 HR88  /  BP 164/90 HR 90 RR18  /  BP 167/95 HR94 R16
Migraine; Dizziness; Joint pain; This is a spontaneous report from a non-contactable consumer, the patient. A 50-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 26Aug2021 at 12:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included gluten allergy, hypothyroid, adrenal insufficiency and wheat allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included sertraline (MANUFACTURER UNKNOWN) and pravastatin (MANUFACTURER UNKNOWN) both for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 05Aug2021 at 12:45 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. On 27Aug2021 at 04:00, the patient experienced migraine, dizziness and joint pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events migraine, dizziness and joint pain were recovering at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
On 2/21/10, pt suffered a severe seizure and was transported by ambulance to the hospital where she was hospitalized for two nights and underwent many tests.
off label use; Interchange of vaccine products; Despite 2 shots of Moderna +Pfizer booster-last Wednesday I tested positive for Covid; Despite 2 shots of Moderna +Pfizer booster-last Wednesday I tested positive for Covid; Despite 2 shots of Moderna +Pfizer booster-last Wednesday I tested positive for Covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Moderna covid-19 vaccine (Dose: 1), for COVID-19 immunization; Moderna covid-19 vaccine (Dose: 2), for COVID-19 immunization. The following information was reported: OFF LABEL USE (medically significant), outcome "unknown", described as "off label use"; INTERCHANGE OF VACCINE PRODUCTS (medically significant), outcome "unknown", described as "Interchange of vaccine products"; IMMUNISATION (medically significant), outcome "unknown", DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 29Dec2021, outcome "unknown" and all described as "Despite 2 shots of Moderna +Pfizer booster-last Wednesday I tested positive for Covid". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (29Dec2021) positive.  Additional information: The symptoms were minimal-mostly scratchy throat that disappeared in hours-never any fever or loss of taste. The patient was isolating and wearing mask and thankfully neither wife nor daughter was positive.   The lot number for bnt162b2 was not provided and will be requested during follow up.
Patient received booster dose early . Patient received second dose of Pfizer on September 20, 2021 and booster on 01/07/2022.  Patient was monitored and no adverse event occured. Follow up call was made to patient and they are fine.
Felt a little tired on Friday 4/27/07 with a little redness over vaccine site on left triceps area. On Saturday, 4/28/07, woke up feeling fine, but after a couple hours, she felt really tired (like she worked a double shift) and felt feverish (did not check temperature; no sweats or chills). She noted that the back of her left arm was red, swollen, tender, warm and pruritic. This worsened a little on Sunday (redness, warmth, swelling and tenderness extended to left elbow). She also noted 2 days of intense aching at old Right tib-fib fracture site (This normally only occurs with significant weather changes and there were no significant weather changes over the week-end.) No other systemic symptoms. By Monday, the local reaction was improving (area smaller with less pruritus). Takes Mobic q day. By Tuesday, 5/1/07, there was an area of about 1' in diameter of redness, induration, tenderness and increased warmth. Pruritus reported as minimal.
The patient started bleeding from the injection site right after the vaccine was given. Within a matter of seconds, while cleaning up the blood, I noticed that he had developed a lump at the injection site. It was a little less than one cm in diameter and 2-3mm in height.
This case was reported by a other health professional and described the occurrence of vaccine overdose in a 48-year-old female patient who received ENGERIX B pediatric (batch number: AHBVC200BA expiry date 8th FEBRUARY 2015). ON an unknown date, the patient received ENGERIX B pediatric. On an unknown date, an unknown time after receiving ENGERIX B pediatric, the patient experienced vaccine overdose, in appropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the vaccine overdose, inappropriate age at vaccine administration and wrong vaccine administered were unknown.
This spontaneous report as received from a health professional refers to a 7 year old patient of unknown gender. There was no information about the patient's concurrent condition, concomitant therapies or medical history provided. On 16-NOV-2015, the patient was vaccinated with an improperly stored dose of VARIVAX lot # L024256, expiration date: 01-JUL-2017 (exact dose and route of administration were not reported). The temperature excursion of the administered dose of vaccine was 20.3 degrees Fahrenheit for 72 hours. Data logger was involved. There were no previous excursions reported. There was no adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
tremors started no more than 7 hours later, woke up from tremors. on day 2 of tremors whole upper body shaking. better on day 3 when seen in clinic as new patient but could see tremor. DTRs normal. weakness with R arm (shot given in L arm). tremor at rest. poor R hand coordination
hearing loss in right ear; This is a spontaneous report received from a contactable consumer. The reporter is the patient. A 42-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm right, administration date 09Nov2021 12:00 (Lot number: FH8028) at the age of 42 years as DOSE 1, SINGLE for COVID-19 immunisation. The patient received second dose of BNT162B2 (lot number: 330308D) in right arm on 30Nov2021 at 12:00 pm at single dose for COVID-19 immunisation. The patient had no relevant medical history. No COVID prior vaccination, no COVID tested post vaccination, no known allergies, no other vaccine in four weeks. There were no concomitant medications. The following information was reported: DEAFNESS UNILATERAL (medically significant) with onset 09Nov2021 13:00, outcome "not recovered", described as "hearing loss in right ear". Therapeutic measures were not taken as a result of deafness unilateral.  No follow-up attempts are possible. No further information is expected.
After vaccination, patient began to feel dizzy after a few minutes and subsequently fainted. she regained consciousness before EMTs arrived and was assessed, all vitals normal, patient declined further medical care. no further issues.
Administration after temperature excursion; In February their fridge was up and down, they have an average temperature of 31.1 degrees F; Administration after temperature excursion; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Administration after temperature excursion), PRODUCT STORAGE ERROR (In February their fridge was up and down, they have an average temperature of 31.1 degrees F) and POOR QUALITY PRODUCT ADMINISTERED (Administration after temperature excursion) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Administration after temperature excursion), PRODUCT STORAGE ERROR (In February their fridge was up and down, they have an average temperature of 31.1 degrees F) and POOR QUALITY PRODUCT ADMINISTERED (Administration after temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Administration after temperature excursion), PRODUCT STORAGE ERROR (In February their fridge was up and down, they have an average temperature of 31.1 degrees F) and POOR QUALITY PRODUCT ADMINISTERED (Administration after temperature excursion) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No Concomitant product use was reported. The reporter who was an HCP reported that in February their fridge was up and down, they had an average temperature of 31.1 degrees F. The minimum temperature was 28.9 degrees F, and the maximum temperature was 40.4 degrees F. Reportedly, the patient administration: the reporter doesn't remember, there might have been. No treatment information was provided.
Sensation that "everything hurts"; Feeling not coherent; "COVID brain" with lightheadedness; "Covid brain" with lightheadedness; Arm pain; A spontaneous report was received from a health professional concerning a 48-year-old, male patient who received Moderna's COVID-19 vaccine and experienced arm pain, "COVID brain" with lightheadedness, felt not coherent and a sensation that "everything hurt".  The patient's medical history included COVID-19 infection one month prior. He has continued nausea, mild headaches, no taste and smell sensations.  Concomitant products known to have been used by the patient, within two weeks prior to the event, included adalimumab.   On 29 Dec 2020, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 025L20A) via unknown route in the left shoulder for prophylaxis of COVID-19 infection.    On 29 Dec 2020, after the vaccination, the patient experienced pain in his arm. On 30 Dec 2020, the patient developed "covid brain" accompanied by lightheadedness, felt not coherent and had a sensation that everything hurt.   Treatment for the event included acetaminophen.  Action taken with the second dose of mRNA-1273 in response to the event was not reported.    The events, arm pain, "covid brain" with lightheadedness, felt not coherent and a sensation that "everything hurt", were considered recovered on 04 Jan 2021.; Reporter's Comments: Based on the established safety profile and a temporal association between the reported events of experienced arm pain, "covid brain" with lightheadedness, felt not coherent and a sensation that "everything hurt and administration of mRNA-1273 vaccine, a causal association cannot be excluded.
Raised, hard, red, itchy lump at injection site, 1 week after injection
Pt developed a rash on both arms and torso 9 days after the shot, she noted that her arm pain from the injection just recently went away (lasted about 2 weeks if she "pushed on the site of injection") she also noted that she had leg swelling before the injection but noticed it was worse after the injection when the rash started she is unsure if they are related.  The patient self treated with benadryl and is currently doing well.
Severe hives all over his body, some swelling in face, tiredness, irritability, wheezing. The symptoms started slightly several hours after immunizations and then gradually got worse until it turned into an extreme case of hives and swelling 4 days after vaccines.
Information has been received froma  physician concering a 7-year-old male patient with a history of pneumonia in January of 1997 who on 04-OCT-1995 was vaccinated with one dose of VARIVAX vaccine SC. On 11-DEC-1997 the patient presented to the physician's office with Herpes Zoster that consisted of "dermatomal lesions" on left abdomen as well as up left flank but crossing midline. The lesions were blistered and fluid-filled. Specimens were sent to a laboratory for analysis via polymerase chain reaction. Additional information has been requested.
sicker than I have ever been; Initial information received on 10-Oct-2020 regarding an unsolicited valid non-serious case from a consumer (patient) via social media.  This case is linked to case id : 2020SA294166, 2020SA294158, 2020SA294157, 2020SA294125 (same reporter).  This case involves a patient of unknown demographics who got sicker than he/she had ever been (illness), after receiving INFLUENZA VACCINE.  The patient's medical history, past medical treatments, vaccinations, concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiration date not reported) via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient got sicker than he/she had ever been (illness) (non-serious event) (unknown latency) following the administration of INFLUENZA VACCINE.  No laboratory data reported.  It was not reported if the patient received a corrective treatment.  At the time of report, the outcome was not reported for the event.  There will be no information on the batch number for this case.
Breakthrough case admission after 2 vaccines 2/25/21 Lot# 010A21A;  Moderna 3/25/21 Lot# 047A21A
Patient was admitted to Hospital on 11/3/2021 for COVID related symptoms. This is considered a breakthrough case.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 63-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 23Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "asthma" (unspecified if ongoing); "seasonal allergies" (unspecified if ongoing), notes: seasonal allergies; "obesity" (unspecified if ongoing). Concomitant medication(s) included: ADVAIR, start date: Jan2019; ARMOUR THYROID, start date: Jan1996. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical information: Patient was treated with Paxlovid (Lot number GA8200) from 24May2022 to 01Jun2022. Continued to have a sore throat, cough, fatigue and swollen glands throughout treatment, though was improving. 2 days later return of nasal congestion/sneezing, sore throat, cough, fatigue and swollen glands  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: As there is limited information in the case provided, the causal association between the reported events with the suspect drug BNT162B2 cannot be excluded. The case will be reassessed once new information is available.
Information has been received from a 40 year old female patient with neuropathy, depression, thyroid problem and stomach problem and who was allergic to aspirin, erythromycin, clindamycin; some food allergies as oysters and allergic to pollen; who "last Wednesday" (on 13-APR-2011) was vaccinated at the back of the right arm with a dose of ZOSTAVAX (Merck) (lot# not specified). Concomitant therapy included NEURONTIN, Mirtazapine (MSD), levothyroxine Na and "Platonix". The patient reported that the same afternoon after receiving the dose of ZOSTAVAX (Merck) (on 13-APR-2011), she experienced injection site reaction. Her right arm became swollen and really puffy, was itchy and red hot to touch. She stated she showed her Dad, who was pharmacist, and he told her to use cortisone cream (unspecified). The patient stated her arm was still swollen but she thought the cream was starting to help since the swelling had decreased somewhat, and the site was not as hot. She stated that she still had a ring of red at the site. No lab diagnostic studies were performed. Follow up information has been received from a female business staff from the physician's office who stated that original patient's adverse event could not be located. She had no new information about the patient's adverse event. She also stated the patient did not get ZOSTAVAX (Merck) in the physician's office. No further information is available.
48-72 hr after H1N1 developed myalgia, headaches, fever, sore throat. Rested today.
jittery; This spontaneous case was reported by a consumer and describes the occurrence of FEELING JITTERY (jittery) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING JITTERY (jittery). At the time of the report, FEELING JITTERY (jittery) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment information not provided   This case was linked to MOD-2021-044125 (Patient Link).
Feb & fussy in late afternoon lt leg sore 9APR91 MN t105, dec appetite, inc sleepiness; 4AM: had tonic/clonic movements of ext/unresponsive x 30sec, emesis x 1 this AM 10APR91;
I woke up the next morning and my tongue feels like it?s burned, it?s very sensitive.   It has not gone away and I don?t know what to do about it?
The next day after !st vaccine (1/7/21) I had a red, swollen, hot area at the injection site. That lasted 2 days and went away. On 1/13/21 in the evening, the swelling, redness and heat came  back at the injection site and is still present.
My r hand swelled up was treated at hospital. Was discharged. Then was rushed to er next morning with hr of 180 and sky high glucose and blood pressure.
Side affects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side affects) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side affects). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (Side affects) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No concomitant medications were reported.   Reporter did not allow further contact
Received vaccine during week 32 of pregnancy as advised. No prior history of adverse reaction. Following day after receiving vaccine I woke up extremely sick and was for about 48 hours. I had a fever, body aches, chills, low energy, loss of appetite, injection site pain (all symptoms were abnormal at the time during pregnancy and compared to prior vaccinations).
The arm was still red and hard; The arm was still red and hard.The redness started going away and it's back and it's worst; Developed a rash on her arms and her legs; This spontaneous case was reported by a consumer and describes the occurrence of INDURATION (The arm was still red and hard), ERYTHEMA (The arm was still red and hard.The redness started going away and it's back and it's worst) and RASH (Developed a rash on her arms and her legs) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported. ).    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INDURATION (The arm was still red and hard), ERYTHEMA (The arm was still red and hard.The redness started going away and it's back and it's worst) and RASH (Developed a rash on her arms and her legs). At the time of the report, INDURATION (The arm was still red and hard), ERYTHEMA (The arm was still red and hard.The redness started going away and it's back and it's worst) and RASH (Developed a rash on her arms and her legs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were provided by the reporter.   Patient used an itch cream on the arms and legs where it was breaking out to treat the symptoms.
admitted to hospital for subarachnoid hemorrhage from syncopal event in the setting of diagnosis of covid on 11/9/22. Transferred to another hospital on 11/17/22.
Around 6 hours post vaccine I began having severe sleep disturbances. Lucid dreams which caused me to sleep walk posing a danger to myself along with calling people. I was completely asleep and have no recollection. Around 12 hours I began having intense chest and rib pain. It was a constricting type of pain. At closer to  18 hours walking became very difficult. Pain in full body is becoming unmanageable.
Patient reported that she experienced face/lip swelling.  Patient stated that she reported feeling "weird" and pharmacist confirmed with patient that she was not experiencing throat swelling.  Patient took Benadryl.  Patient has since seen primary care physician who prescribed an Epipen and recommended that the patient receive Pfizer for dose #2.
Previously healthy 46 yoM received moderna dose 1 on 4/9.  On 4/13 starts noticing a petechial rash on bilateral feet.  This spreads up the legs with some involvement in the torso.  On 4/15 notices mucosal bleeding with gums while brushing teeth, increasing spontaneous nose bleeds overnight.  On 4/21 has a telehealth PCP visit, sent for lab work which shows thrombocytopenia with a platelet count of 2k as well as a hemoglobin of 12.9.  Is sent to the ED with repeat platelet count of 1k.  Previously platelets were 143k  in 2019.  Pt admitted for further work-up